MSB Reports Q3 Financial Results and Operational Highlights
Filed with ASX · · 8 pages · English
In the deck
Story so far
Earlier from Mesoblast
- Third Quarter Financial Results on Form 6-K
- Reinstatement to Official Quotation
- Mesoblast Completes Private Placement
- Voluntary Suspension
- FDA Accepts Mesoblasts BLA Resubmission for Remestemcel-L
Later from Mesoblast
- Update on BLA for Graft Versus Host Disease
- MSB Launches Entitlement Offer and Placement
- Entitlement Offer and Placement Investor Presentation
- Mesoblast Completes Institutional Allocation
- Information For Retail Shareholders
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast